Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03527537 · ClinicalTrials.gov registry record · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
A Phase 4 study of Gestational Diabetes, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 416
- Enrollment target
- 1
- Study location
NCT03527537 is a Phase 4 study of Gestational Diabetes that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 416 participants, above the 312-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03527537, a Phase 4 study of Gestational Diabetes, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 416 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare two different thresholds for initiation of medical treatment for GDM. Pregnant women diagnosed with GDM will be randomized to either start pharmacotherapy when they have reached at least 20% or at least 40% of capillary blood glucose (CBG) values above the target goal. The investigators hypothesize that a lower threshold of 20% elevated CBG levels, compared to 40%, will lead to lower rates of obstetric and medical complications.
Conditions Studied
Interventions
- DRUG Insulin
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2021-05-04 |
| Est. Completion | 2026-10-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03527537
The ClinicalTrials.gov registry entry for NCT03527537 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 416 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 312-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (33% higher). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gestational Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Insulin is the first listed.
NCT03527537 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03527537 about?
NCT03527537 is a clinical study titled "Gestational Diabetes and Pharmacotherapy (GAP)". The goal of this study is to compare two different thresholds for initiation of medical treatment for GDM. Pregnant women diagnosed with GDM will be randomized to either start pharmacotherapy when they have reached at least 20% or at least 40% of capillary blood glucose (CBG) values above the target...
What is the current status of trial NCT03527537?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 416 participants. The study started on 2021-05-04. Estimated completion is 2026-10-01.
What conditions does trial NCT03527537 study?
This clinical trial studies the following conditions: Gestational Diabetes.
What interventions are being tested in trial NCT03527537?
The interventions under investigation include: Insulin (DRUG).
Who is sponsoring clinical trial NCT03527537?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03527537 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GDM: Insulin with or Without Metformin?
RECRUITING · Phase 4
-
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
RECRUITING · Phase 4
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.